Firalis develops biomarkers and biomarker-based diagnostic kits to improve disease outcomes and patient comfort, increase therapeutic decisions and finally to reduce healthcare costs remarkably. Most products involve biomarkers that are related to inflammatory disorders including common diseases such as atherosclerosis, rheumatoid arthritis or rare/orphan diseases such as systemic or autoimmune vasculitis. Lucerna-Chem is the official Swiss distributor, enabling you convenient domestic orders for all products listed in the webshop.
ISO 9001, ISO 13485, ISO 17025, GCLP, NF S 96-900
2-5 business days